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ABSTRACT 
Background: Increased intracranial pressure (ICP) worsens the outcome of acute liver failure (ALF). This study 
investigates the underlying pathophysiological mechanisms and evaluates the therapeutic effect of albumin dialysis 
in ALF with use of the Molecular Adsorbents Recirculating System without hemofiltration/dialysis (modified, M-
MARS). 
Methods: Pigs were randomized into three groups: sham, ALF, and ALF + M-MARS. ALF was induced by hepatic 
devascularization (time = 0). M-MARS began at time = 2 and ended with the experiment at time = 6. ICP, arterial 
ammonia, brain water, cerebral blood flow (CBF), and plasma inflammatory markers were measured. 
Results: ICP and arterial ammonia increased significantly over 6 hrs in the ALF group, in comparison with the sham 
group. M-MARS attenuated (did not normalize) the increased ICP in the ALF group, whereas arterial ammonia was 
unaltered by M-MARS. Brain water in the frontal cortex (grey matter) and in the subcortical white matter at 6 hrs 
was significantly higher in the ALF group than in the sham group. M-MARS prevented a rise in water content, but 
only in white matter. CBF and inflammatory mediators remained unchanged in all groups. 
Conclusion: The initial development of cerebral edema and increased ICP occurs independently of CBF changes in 
this noninflammatory model of ALF. Factor(s) other than or in addition to hyperammonemia are important, 
however, and may be more amenable to alteration by albumin dialysis. 
Keywords: liver ischemia, cerebral blood flow, cerebral edema, inflammation 
INTRODUCTION 
Raised intracranial pressure (ICP), in conjunction with cerebral edema, is a common complication of acute liver 
failure (ALF), contributing significantly to mortality and morbidity (1–5). The underlying pathophysiological 
mechanisms are not entirely clear, but hyperammonemia is a consistent finding and is believed to play a major role 
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(6). This is emphasized by studies in which ammonia-lowering strategies prevented brain edema and severe 
encephalopathy in rats with ALF (7, 8). It has also been suggested that increased cerebral blood flow (CBF) may be 
coupled with intracranial hypertension in ALF (9). However, whether increased CBF is a cause of raised ICP 
(temporally preceding it), an effect, or just an association remains unclear. Recently, it has been demonstrated that 
other factors such as inflammation and subliminal infection may be involved in the pathophysiology of intracranial 
hypertension in ALF (10, 11). 
Recent studies have investigated the role of Molecular Adsorbents Recirculating System (MARS) in liver failure (12–
14). This is an extracorporeal device (15–17) utilizing albumin dialysis with hemofiltration/dialysis to remove 
albumin-bound toxins (18) that accumulate in liver failure and thus may improve/prevent associated cerebral, renal, 
and circulatory disturbances (12, 19). One consistent observation with its use in patients with liver failure has been 
an improvement of hepatic encephalopathy (12–14, 20). However, most of the data pertain to patients with acute 
decompensation of chronic liver disease, and the effect of MARS therapy on cerebral status in ALF remains unclear. 
A porcine model of ALF induced by hepatic devascularization has been developed and validated (21–24) and shows 
the characteristic rise of ICP, with a concomitant increase in blood ammonia and hyperdynamic vasodilated 
circulation, renal dysfunction, and worsening liver function characterized by coagulopathy and hyperbilirubinemia 
(21–24). The present study utilizes this model to better understand the pathophysiological basis of intracranial 
hypertension and investigates the impact of albumin dialysis with use of MARS without any hemofiltration/dialysis 
(which we have termed modified MARS [M-MARS]) on the development of increased ICP in ALF, in relation to 
arterial ammonia, cerebral edema (measuring brain water), CBF, and plasma inflammatory mediators—factors 
thought to be of pathophysiological importance in ALF. 
METHODS 
The study was performed at the Surgical Research Laboratory, University of Tromsø, Norway, with approval of the 
Norwegian Experimental Animal Board. Twenty-four female Norwegian Landrace pigs from three different litters, 
weighing 23–30 kg (mean ± sem, 26.8 ± 0.3) were used, and all the studies were performed by the same 
investigators (SS, CR, LMY, GIN, SSD, and MK) over a 3-month period. The operating theater and all the associated 
facilities remained unchanged throughout the experimental period. 
Study Design. 
The pigs were randomized according to sealed, prenumbered envelopes into one of three groups: sham, ALF, and 
ALF + M-MARS (eight per group) (Fig. 1). Details of the surgery, including sham operation, are described elsewhere 
(21, 24). In brief, in the sham group, sham abdominal surgery was performed without interfering with hepatic blood 
supply. In the other two groups, hepatic devascularization was performed by an end-to-side porta-caval anastomosis 
followed by hepatic artery ligation. Time = 0 hrs was set with ligation of the hepatic artery (ALF, ALF + M-MARS) or 
completion of surgery just before the closing of the abdominal wall (sham). All pigs were monitored over the 
following 6 hrs. In the ALF + M-MARS group, albumin dialysis was instituted for 4 hrs, from time = 2–6 hrs. 
Experiments were terminated with an overdose of pentobarbital and potassium chloride at time = 6 hrs. 
The Animal Model. 
Details regarding animal room facilities, anesthesia, and surgical preparation has previously been reported (21–25). 
All animals received 500 mL 0.9% NaCl containing 625 mg of glucose as a preoperative load in order to prevent any 
preoperative dehydration. The pigs were premedicated with intramuscular ketamine (20 mg/kg) and atropine (1 
mg). Anesthesia was induced with an intravenous bolus of 10 mg/kg pentobarbital and 10 µg/kg fentanyl and was 
maintained during surgery with a central venous infusion of 4 mg/kg/hr pentobarbital, 0.02 mg/kg/hr fentanyl, and 
0.3 mg/kg/hr midazolam. Anesthesia was stopped after hepatic devascularization. If clinical signs of light sedation 
appeared, small doses of fentanyl and midazolam were given as boluses. Because of drug removal by MARS (25), ALF 
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+ MARS animals were kept sedated by a continuous infusion of 0.04 mg/kg/hr fentanyl and 0.6 mg/kg/hr 
midazolam, with additional boluses given when clinically indicated. 
The pigs were ventilated (Paco2, 4.5–5.0 kPa) throughout the experiment and were infused with 0.9% NaCl (at 3 
mL/kg/hr), 50% glucose (at 0.6 mL/kg/hr, except for sham-operated animals, which received only half that amount 
to make the glucose levels comparable between the groups), and 20% human albumin (at 0.66 mL/kg/hr, to 
counteract intra-abdominal fluid loss during and after surgery), as described previously (21–25). Normal core body 
temperature was maintained at 38.5 ± 1°C. Heparin was used to keep the activated clotting time >100 sec (>180 sec 
during MARS). 
Figure 1.An outline of the study design (ALF, acute liver failure; ICP, intracranial pressure; M-MARS, 
modified Molecular Adsorbents Recirculating System). 
Catheter Placement. 
A very thin catheter developed by Ten Have et al. (26, 27) was introduced into the abdominal aorta. MARS was 
performed through an 11.5-French dual lumen catheter (Mahurkar, Tyco Healthcare, Gosport, Hampshire, UK) in the 
inferior vena cava (positioned during abdominal surgery). ALF and sham animals also received a vena caval catheter 
to be comparable. A 7-French pigtail catheter (Cordis, Miami, FL) was inserted via the left carotid artery into the left 
ventricle of the heart for microsphere injection. Position was confirmed by online pressure curves. 
Use of M-MARS. 
MARS (Monitor 1, Teraklin AG, Rostock, Germany) (15) dialyses blood across an albumin-impregnated membrane 
against 20% human albumin, the premise being that albumin-bound toxins in the blood detach, bind to free binding 
sites on the membrane, and pass on to albumin in the dialysate. Normally, the dialysate is then cleansed by 
hemodialysis/filtration (removing water-soluble toxins) and activated charcoal and anion-exchanger (adsorbing 
albumin-bound toxins), is “regenerated,” and adsorbs more toxins from the blood (15, 16, 18). Because the present 
study was designed to specifically evaluate the role of albumin dialysis in ALF, hemofiltration/dialysis was not 
performed (i.e., there was no additional removal of free water/water-soluble toxins, other than what might be 
removed by a closed-circuit recirculating albumin dialysis), and the renal part of the circuit was clamped off. Thus, 
this was a modified MARS circuit (M-MARS). Albumin recirculation continued, as has been previously described (Fig. 
2). A roller pump (Stöckert Shiley, Munich, Germany) was used to run the blood circuit at 150 mL/min, with the 
albumin dialysate circulated by the MARS pump also at 150 mL/min. 
Sen, S. et al., 2006. Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. 
Critical Care Medicine, 34(1), p.158-164. 
The final publication is available at http://dx.doi.org/10.1097/01.CCM.0000196203.39832.3C 
 
 
 
 
 
 
 
 
 
Figure 2.A schematic diagram of the modified Molecular Adsorbents Recirculating System (M-MARS) circuit. Blood 
is dialyzed against 20% albumin across the MARS membrane. The albumin dialysate is sequentially cleansed by the 
activated charcoal column and the anion exchange resin column and is thus recirculated. The segments for the renal 
module of the circuit have been clamped off. 
ICP Monitoring. 
A burr hole was created over the right frontal region of the skull (2 cm lateral, 1 cm rostral from bregma and 1 cm 
ventral), the dura mater was incised, and a stable drift-free ICP transducer for continuous measurements (Codman 
MicroSensor, Johnson & Johnson, Raynham, MA) was inserted into the frontal cortex at least 1 hr before completion 
of abdominal surgery. The burr hole was sealed with bone wax to ensure stable positioning of the catheter and to 
prevent pressure release. ICP monitoring has been described in detail elsewhere (21–24). Average values from the 
last 5 mins before each time point were used for analysis of the continuous data. After the experiments were 
terminated, a craniotomy was performed and the brain was examined for any intracranial hemorrhage. 
Brain Water Measurement. 
Following termination of the experiments, the brain was rapidly removed and samples were dissected from the 
frontal cortex (grey matter) and adjacent subcortical white matter of the frontal lobe, as well as the cerebellar cortex. 
Brain tissue water content (measure of cerebral edema) was determined by the previously described gravimetric 
technique, with use of kerosene and bromobenzene to generate a liquid column with a known linear density gradient 
(28). 
CBF Measurement. 
The method of blood flow determination with fluorescent microspheres has been described in detail elsewhere (29). 
In brief, 1 × 106 fluorescent microspheres (polystyrene, 15.5 µm ± 2%; Molecular Probes, Eugene, OR) were injected 
via the left ventricular catheter at time = 0 and 6 hrs. Simultaneously, a reference arterial sample was collected from 
the arterial cannula at 4 mL/min × 2 mins (Harvard withdrawal pump, Harvard Apparatus, Millis, MA) which 
allowed for the calculation of absolute blood flow. At time = 6 hrs, brain tissue samples (forebrain, cerebellum) were 
collected and stored at -80°C until analysis. Samples were weighed before digestion in ethanolic KOH (Sigma, Poole, 
UK) in a 60°C oven over 24 hrs, before vacuum filtration through an 8-µm polycarbonate membrane (Kunstoff, 
Grafenhausen, Germany) (30). The filtered microspheres were washed with 1% Triton-X 100 (Sigma) and stored in 
the dark until measurement. Immediately before measurement, the microspheres were dissolved in diethylene 
glycol monoethyl ether acetate (Sigma) and analyzed with a fluorescence spectrometer (LS50B, Perkin-Elmer, 
Norwalk, CT) and an autosampler and diluter station with common autosampler software (models AS90/91and DS6, 
respectively, FLWinLab, Perkin-Elmer). Values are expressed as mL/min/100 g tissue (wet weight). 
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Plasma Measurements for Ammonia and Inflammatory Mediators/Surrogate Markers.  
Arterial blood was collected every 2 hrs and centrifuged, and the plasma was stored at -70°C for subsequent analysis. 
Ammonia levels were determined with an ammonia reagent kit (171-B, Sigma Diagnostics, St. Louis, MO) by an 
automated enzymatic method (Cobas Fara II, Roche, Basel, Switzerland). Cytokines (interleukin [IL]-6, IL-8, and 
tumor necrosis factor [TNF]-[alpha]) were detected with commercially available porcine cytokine sets (R&D 
Systems, Minneapolis, MN) used according to the manufacturer’s instructions (lower limit for detection, 5 pg/mL). 
Malondialdehyde was detected with a modified Thiobarbituric Acid Reactive Substances (TBARS) assay, described 
by Lapenna et al. (31), wherein the major interfering/oxidizable component in the plasma is inhibited by addition of 
sodium sulfate. F2-isoprostanes (free 8-isoprostane F2[alpha]) was assayed with a commercial enzyme 
immunoassay kit (Cayman Chemical, Ann Arbor, MI) according to the manufacturer’s instructions; 200 µL plasma 
was deproteinized with 600 µL ethanol containing 3H-prostaglandin E2 (3H-PGE2) as an internal standard to 
account for losses. After centrifugation the supernatant was reduced to near-dryness, and 2 mL acetic acid was 
added and applied to a preconditioned C18 SPE cartridge (Waters, Milford, MA). The column was washed with water, 
dried with nitrogen, and eluted with high-performance-liquid-chromatography-grade hexane. The prostanoid 
fraction was eluted with 5 mL ethylacetate containing 1% methanol, the eluant was reduced to dryness and 
reconstituted in 450 µL of enzyme immunoassay buffer (100 µL was used to determine recovery of 3H-PGE2), and 
50 µL was added to the enzyme immunoassay plate with isoprostane tracer and antibody. Isoprostane levels were 
determined with reference to authentic standards and were corrected for losses. 
Statistics. 
Results are expressed as mean ± sem. Significance of difference within a group was tested by paired Student’s t-test, 
and between-groups differences were tested by unpaired Student’s t-test or two-way ANOVA, as appropriate; p < .05 
was considered statistically significant. GraphPad software (Prism 4.0, GraphPad Software, San Diego, CA) was used. 
RESULTS 
Three pigs were excluded: one sham and one ALF, because of intracranial hemorrhage, and one ALF, because of 
technical problems with ICP monitoring; 21 pigs (sham, 7; ALF, 6; ALF + M-MARS, 8) were ultimately included. 
Intracranial Pressure. 
Following liver devascularization, the ALF group (7.0 ± 0.8 to 15.5 ± 1.7 mm Hg) developed a significant increase in 
ICP over 6 hrs (121.4 ± 22.1%; p = .005) in comparison with the sham group (8.4 ± 0.9 to 9.7 ± 1.2 mm Hg, a 15.3 ± 
13.1% increase [p > .05]; ALF vs. sham, p < .05). This rise was attenuated in the ALF + M-MARS group (9.1 ± 1.0 to 
14.5 ± 1.6 mm Hg, a 58.9 ± 16.0% increase [p < .001]; ALF + M-MARS vs. ALF, p < .05). However, the ICP in the ALF + 
M-MARS group remained significantly higher than in the sham group (ALF + M-MARS vs. shams, p < .05) (Fig. 3). 
Similarly, the absolute increase of ICP over 6 hrs was significantly greater in the ALF group (8.5 ± 1.5 mm Hg) than in 
the sham group (1.3 ± 0.6 mm Hg; p < .01). This rise was attenuated with M-MARS (5.4 ± 1.0 mm Hg; p < .05 vs. ALF), 
although it was still significantly greater than in the sham group (p < .01). Finally, the area under the curve for 
relative change in ICP (mm Hg) vs. time over the duration of M-MARS dialysis (time = 2–6 hrs) was significantly 
lower with M-MARS (6.5 ± 0.9 mm Hg/hr) than in the ALF group (11.5 ± 2.4 mm Hg/hr; p < .05). 
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Figure 3.Rise of intracranial pressure (ICP, expressed as percentage change from baseline) in the three 
groups over the duration of the study (ALF, acute liver failure; M-MARS, modified Molecular Adsorbents 
Recirculating System). 
Brain Water. 
Brain tissue water content in the grey and white matter of the frontal lobe at 6 hrs was significantly higher in the ALF 
group than in the sham group. M-MARS prevented an increase in ALF-induced water content in the white matter (p = 
.04) but not in the grey matter. Cerebellar water content did not significantly differ between the three groups (Fig.4). 
  
 
 
 
 
 
 
 
Figure 4.Brain water content per unit mass of brain tissue (g water/g tissue, expressed as a percentage) at 
the end of the experiments (time=6) in the three groups of pigs (*p<.05 vs. sham; †p<.05 vs. ALF;ALF,acute 
liver failure;M-MARS,modified Molecular Adsorbents Recirculating System) 
Cerebral Blood Flow. 
CBF, measured at time = 0 and 6 hrs in the forebrain and the cerebellum, was not significantly different over time or 
amongst brain regions within or between any of the three groups (Table 1). 
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Table 1.Cerebral blood flow (ml/min/100 g; mean±SEM) at baseline (time=0 hrs) and at the end of the 
experiments (time=6 hrs) in the three groups of pigs 
 
 
Ammonia. 
Elevation of arterial ammonia occurred over 6 hrs in the ALF group and was significantly higher than in the sham 
group (p < .0001). The ALF + M-MARS group also developed hyperammonemia, which was not significantly different 
from that in the ALF group but significantly higher than in the sham group (p < .0001) (Fig. 5). 
  
   
 
 
 
 
 
 
 
 
Figure 5.Rise in arterial ammonia over the duration of the study period in the three groups (ALF, acute liver 
failure;M-MARS, modified Molecular Adsorbents Recirculating System). 
 
Inflammatory Markers. 
None of the inflammatory mediators or surrogate markers studied (cytokines: IL-6, IL-8, TNF-[alpha]) changed 
significantly over time in any of the groups. Plasma malondialdehyde, an oxidative stress marker, increased 
significantly after 6 hrs in the ALF and ALF + M-MARS groups but not in the sham group. The change relative to 
baseline (time = 0) in the ALF group (120.1 ± 42.0% increase) was significantly higher than in the sham group (22.1 
± 9.3% decrease; p < .01), whereas that in the ALF + M-MARS group (35.2 ± 8.4% increase) was significantly lower 
than in the ALF group (p < .05). The percentage changes were not significantly different between the sham and ALF + 
M-MARS groups, although 6-hr levels were significantly higher in the latter. Plasma F2-isoprostane, another 
oxidative stress marker, did not increase significantly in any of the groups. The increases relative to baseline in the 
ALF (22.1 ± 16.4%) and ALF + M-MARS groups (21.7 ± 15.0%) were significantly higher than in the sham group 
(20.0 ± 7.2% decrease; p < .05) but not significantly different amongst themselves (Table 2). 
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Table 2.Plasma levels of cytokines, malondialdehyde, and F2-isoprostanes in the three groups of pigs at 
baseline (time=0 hrs) and at the end of the experiments (time=6) 
DISCUSSION 
ALF causes cerebral edema, leading to increased ICP and consequent morbidity and mortality (1–4). However, its 
underlying mechanisms have not been fully elucidated. Previous studies have consistently shown an improvement in 
the mental state of patients whose liver failure is treated with MARS (12–14, 20). The present study investigated the 
pathophysiological factors responsible for increased ICP in ALF, with use of M-MARS dialysis as an experimental tool. 
A porcine liver-devascularized ALF model previously demonstrated to have a characteristic increase in ICP (21–24) 
and large enough to evaluate an extracorporeal device was used. The rise of ICP and increase in brain water without 
significant change in CBF and inflammatory markers suggest a significant initiating role of ammonia in the 
pathogenesis of increased ICP in ALF. The attenuation of ICP increase with M-MARS was not due to reduced arterial 
ammonia and was independent of changes in CBF, peripheral inflammatory markers, or systemic hemodynamics 
(which remained unaltered with M-MARS; data reported elsewhere (32)), suggesting that other undefined 
mechanisms are important. Our data also demonstrate asymmetric distribution of brain water, possibly implicating 
different types of astrocytes or other cell types in the pathogenesis of brain edema in ALF. Normalization of brain 
water in the white matter by M-MARS suggests this region is a possible new therapeutic target. 
A noteworthy point is the variation in baseline ICP between the three groups, with the difference between ALF 
(lowest) and ALF + M-MARS groups (highest) tending toward statistical significance (p = .09), although all baseline 
values were still within normal limits. The probable reason is interlitter variation, with uneven distribution of 
animals from the three litters used for the study between the three groups, in spite of the randomization protocol 
used. This confounded analysis of the ICP data with use of actual values of the groups. We therefore analyzed the 
data with use of percentage changes, differences in absolute changes ([DELTA] ICP), and area under the curve for 
relative change in ICP vs. time. All three of the statistical methods used to overcome the difficulties introduced by 
variations in the baseline indicate a significant rise of ICP in ALF in comparison with sham, as well as a significant 
attenuation with albumin dialysis. Moreover, whereas analysis of absolute ICP values is important to interpret the 
clinical relevance of data, the present study was designed to allow early institution of albumin dialysis to attenuate 
an increase in ICP. Thus, the absolute ICP values cannot be directly translated to the clinical setting of ALF, but the 
change in ICP can be used to study underlying pathophysiology. 
Hyperammonemia is thought to be central in the pathogenesis of increased ICP in ALF (6), and this is supported in 
our model where intracranial hypertension was accompanied by rising arterial ammonia in ALF (as opposed to 
sham). Similar arterial levels have previously been shown to be associated with high brain ammonia extraction (33) 
and brain stem herniation in ALF patients (6). However, even though M-MARS attenuated the rise of ICP, 
hyperammonemia persisted, suggesting other factors are important in the development of intracranial hypertension. 
Removal of these putative factors can potentially result in a beneficial lowering of ICP. Unfortunately, the presence of 
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extensive intracranial arteriovenous anastomoses (34, 35) in pigs meant that further analyses for brain ammonia 
flux/extraction (with use of arterial and reverse jugular venous samples) would be difficult to interpret. 
Cytotoxic brain edema is commonly observed in ALF and is thought to be the underlying mechanism of intracranial 
hypertension. Most studies investigating this phenomenon concentrate on brain water changes in the frontal cortex 
(grey matter) in different animal models (7, 8, 36). This study explored the possibility of regional cerebral 
differences by measuring brain water in the frontal cortex (grey matter), adjacent subcortical white matter, and 
cerebellar cortex. In addition to the consistently observed increase in brain water in the grey matter in the ALF 
group, a significant increase was also noted in white matter but not in the cerebellum, a finding emphasizing that 
cerebral edema in ALF is not entirely confined to grey matter. This may provide novel insights into pathogenesis. It is 
known that astrocyte swelling (possibly due to accumulation of the ammonia-detoxification product glutamine) in 
grey matter causes brain edema in ALF (4, 37). However, astrocytes are also found in white matter, although of a 
different type (fibrous astrocytes, compared to protoplasmic astrocytes in grey matter). This suggests that astrocytes 
in general are prone to swell and/or that other cells in white matter (e.g., oligodendrocytes) contribute to brain 
edema in ALF. The additional observation of normalization of white matter water content with albumin dialysis, 
without improvement of grey matter edema, implies that white matter water content may be the more labile 
component and more amenable to therapeutic interventions. Anecdotal reports on rat models of ALF demonstrating 
regional differences of brain water between forebrain (predominantly grey matter) and hindbrain (predominantly 
white matter) (38–40) support our findings. 
Reports of CBF in the setting of ALF have varied widely (41–44), perhaps because of the differences in techniques 
used and the lack of longitudinal observations, which would define a clearer temporal resolution. The technique 
using microspheres has previously been used in pig models and has been shown to compare well with other 
methods of measurement (45–48). In our model, no significant change in CBF in the forebrain or the cerebellum 
(hindbrain) accompanied either the rise in ICP with ALF or the decrease with albumin dialysis. All values observed 
remained within normal limits for pigs. This observation, suggesting that an increase in CBF does not initiate the rise 
in ICP observed in the ALF pig, is at variance with data from experimental studies involving porta-caval-shunted 
ammonia-infused rats (36). This may reflect differences in the models and timing of measurements. Our results are 
supported by observations in patients with ALF, from which we recently showed that increased CBF was associated 
with bursts of ICP, to values >20 mm Hg, but an increase in CBF was not found to be the important initiating event in 
the pathogenesis of intracranial hypertension (49). It is interesting that an ICP >20 mm Hg was observed in only two 
pigs (both 21 mm Hg) in our study. 
We also investigated the role of mediators of inflammation (or surrogate markers) in relation to these cerebral 
effects. Takada et al. (50) showed in a pig model of ALF that animals administered lipopolysaccharide and amatoxin 
intraportally developed greater intracranial hypertension than animals given amatoxin alone. ALF patients who had 
higher systemic inflammatory response syndrome scores or who were overtly infected were more likely to develop 
intracranial hypertension (51, 52). Malondialdehyde levels showed statistically significant changes but remained 
within the normal range and were unlikely to be of pathophysiological relevance. F2-isoprostanes did not increase 
significantly in ALF, but the change from baseline was significantly higher than in the sham group, mainly because of 
a significant reduction in levels in the latter group (perhaps due to recovery from surgical stress). None of the 
proinflammatory cytokines studied increased significantly in any of the groups, suggesting that the cerebral changes 
over 6 hrs in our model developed independently of any inflammation, including oxidative stress. Hence, it was not 
possible to evaluate the role of MARS in removing cytokines, as has been reported recently (53). Our results support 
the notion that inflammation is unlikely to be an important initiating factor in the pathogenesis of intracranial 
hypertension in ALF, but as we have recently observed in ALF patients, it may be more important in the later stages 
of ALF (49). 
The cerebral effects of albumin dialysis observed in the present study were evident with a 4-hr session started 2 hrs 
after the induction of ALF, implying that early institution of therapy for ALF patients might bring about a rapid 
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clinical response. Hemodialysis may worsen intracranial hypertension in ALF (54–56); therefore, closed albumin 
dialysis without additional hemodialysis/filtration may be a worthwhile option. There was no significant change in 
arterial ammonia levels, even though ammonia was detectable in the MARS dialysate (data not shown). Although it is 
possible that absence of the renal circuit in M-MARS could have reduced ammonia removal, the results of the present 
study are in keeping with our previous observation with conventional MARS (with continuous venovenous 
hemofiltration) in patients with acute or chronic liver failure, of marked improvement of hepatic encephalopathy 
despite unchanged arterial ammonia (even though ammonia was being removed by the circuit) (57). 
In the present study, a modified MARS circuit was used without any renal replacement module to evaluate albumin 
dialysis without additional removal of water-soluble toxins. Although this was advantageous in studying the 
underlying pathophysiological changes, our results cannot be directly extrapolated to systems using albumin dialysis 
with hemofiltration/dialysis. On a similar note, porcine blood was dialyzed against human albumin. Human and 
porcine albumin have similar molecular weights (66–67 kDa) (58), and although their binding properties do vary 
(59), their affinity for substances such as bilirubin are very similar (60). Thus, although the exact rate of change may 
be affected by this interspecies difference, we believe our results to be essentially valid for albumin dialysis in 
human patients. On a similar note, although human albumin was intravenously infused into the pigs, no reaction was 
observed against the xenogenic protein, which is in keeping with all the previous observations in studies using this 
model (21–24). 
The results of this study show that M-MARS has beneficial effects on ICP in a devascularized pig model of ALF. 
Regional differences exist for brain edema, with white matter edema being more amenable to therapeutic 
interventions such as albumin dialysis. Unidentified factors in addition to hyperammonemia appear to be important 
in the pathogenesis of increased ICP in ALF, which are altered by albumin dialysis. Identifying these putative factors 
and understanding their intracerebral effects may provide novel therapeutic targets. 
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